OZEM vs. LGHT ETF Comparison
Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to Langar Global HealthTech ETF (LGHT)
OZEM
Roundhill GLP-1 & Weight Loss ETF
OZEM Description
OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.
Grade (RS Rating)
Last Trade
$25.29
Average Daily Volume
37,622
14
LGHT
Langar Global HealthTech ETF
LGHT Description
LGHT targets the global healthcare technology industry. The fund actively invests in HealthTech companies, which the adviser defines as firms that develop technology designed to create healthcare efficiency by addressing key pain points for patients, providers, payors, and hospitals, including those companies that derive a majority of their revenue from HealthTech products and services. The portfolio construction starts by identifying companies that fit into the advisers HealthTech definition. The remaining companies are screened using a proprietary metric that assesses each firms financial health, involvement in relevant controversies, as well as the strength of its team and culture. Each company is then assigned an industry risk score through an algorithm that defines quantitative and qualitative risk categories and weights them accordingly. Finally, each company is reviewed by an investment committee. However, the portfolio manager still has full discretion over the final selection.Grade (RS Rating)
Last Trade
$10.35
Average Daily Volume
915
31
Performance
| Period | OZEM | LGHT |
|---|---|---|
| 30 Days | -10.60% | -1.96% |
| 60 Days | -11.17% | -2.17% |
| 90 Days | -12.25% | -1.81% |
| 12 Months |
0 Overlapping Holdings
| Symbol | Grade | Weight in OZEM | Weight in LGHT | Overlap |
|---|
OZEM Underweight 31 Positions Relative to LGHT
| Symbol | Grade | Weight | |
|---|---|---|---|
| ISRG | A | -15.39% | |
| GEHC | D | -8.56% | |
| RMD | C | -6.71% | |
| IQV | F | -6.34% | |
| DXCM | C | -5.51% | |
| PODD | C | -5.26% | |
| VEEV | C | -5.15% | |
| PHG | C | -4.87% | |
| ZBH | C | -3.57% | |
| BNTX | C | -3.53% | |
| ALGN | D | -2.85% | |
| MASI | B | -2.46% | |
| DOCS | C | -2.06% | |
| MRNA | F | -1.72% | |
| PRCT | B | -1.27% | |
| ALKS | C | -0.66% | |
| TNDM | D | -0.54% | |
| IRTC | C | -0.44% | |
| PRVA | C | -0.44% | |
| OMCL | C | -0.42% | |
| LFST | B | -0.31% | |
| TDOC | C | -0.28% | |
| PGNY | F | -0.25% | |
| EVH | F | -0.22% | |
| SDGR | C | -0.21% | |
| GDRX | F | -0.2% | |
| ALHC | C | -0.2% | |
| PHR | F | -0.17% | |
| ACCD | D | -0.07% | |
| MODV | C | -0.03% | |
| TBRG | B | -0.03% |
OZEM: Top Represented Industries & Keywords
LGHT: Top Represented Industries & Keywords
Compare ETFs
